Article
Human pan-cancer analysis of the predictive biomarker for the CDKN3
8 May 2024
Abstract excerpt
BACKGROUND: Cell cycle protein-dependent kinase inhibitor protein 3 (CDKN3), as a member of the protein kinase family, has been demonstrated to exhibit oncogenic properties in several tumors. However, there are no pan-carcinogenic analyses for CDKN3. METHODS: Using bioinformatics tools such as The Cancer Genome Atlas (TCGA) and the UCSC Xena database, a comprehensive pan-cancer analysis of CDKN3 was conducted....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
